Schedule 13G ownership disclosure

Prime Medicine Inc

COMMON STOCK · CUSIP: 74168J101

Event date: 2025-12-31

Filing-level shares
5,995,183
Percent of class
3.3%
  • T. Rowe Price Investment Management, Inc.

    Shares: 5,995,183 · Class: 3.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-26-000293
Form type
SCHEDULE 13G/A
Filer
Prime Medicine, Inc.
CIK
CIK 1894562
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub